|Titre :||Cannabis based drugs: how will they be used in practice? (2018)|
|Auteurs :||N. HAWKES|
|Type de document :||Article : Périodique|
|Dans :||British Medical Journal (Vol.363, n°8175, 10 November 2018)|
|Article en page(s) :||k4665|
|Discipline :||SAN (Santé publique / Public health)|
Thésaurus TOXIBASECANNABIS ; USAGE THERAPEUTIQUE ; PRESCRIPTION MEDICALE ; LEGISLATION
It became legal for doctors to prescribe cannabis based drugs on 1 November. But who will be able to issue these products, for what conditions, and what’s the evidence? Nigel Hawkes reports.
Who can prescribe?
Only specialists, and they will be expected to get approval from the chair of their hospital's drug and therapeutics committee, or the medical director, on a named patient basis. GPs cannot prescribe.
What indications are included?
NHS England lists just two: children with rare forms of epilepsy and adults with nausea or vomiting caused by chemotherapy. "Very few people in England are likely to get a prescription for medical cannabis," its guidance to patients says. [Extract]
|Domaine :||Drogues illicites / Illicit drugs|
|Refs biblio. :||6|
|Affiliation :||London, UK|